Data as of Dec 26
| -0.20 / -0.30%|
The 22 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 73.50, with a high estimate of 80.00 and a low estimate of 47.00. The median estimate represents a +10.58% increase from the last price of 66.47.
The current consensus among 28 polled investment analysts is to Buy stock in St. Jude Medical. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.